Refaat S, Al-Rashidi H, El Azeem R, Nouh W, Hamed S, Attia Z
Breast Cancer Res Treat. 2024; 210(1):57-70.
PMID: 39570546
PMC: 11787156.
DOI: 10.1007/s10549-024-07536-y.
Deme D, Tamaskovics B, Jammoul N, Kovacs S, Kayode E, Grice J
Pathol Oncol Res. 2024; 30:1611735.
PMID: 38689824
PMC: 11058978.
DOI: 10.3389/pore.2024.1611735.
Adedokun K, Oluogun W, Oyenike M, Imodoye S, Yunus L, Lasisi S
Sultan Qaboos Univ Med J. 2023; 23(4):526-533.
PMID: 38090235
PMC: 10712386.
DOI: 10.18295/squmj.7.2023.044.
Gaffoor N, Krishnamurthy J
J Lab Physicians. 2023; 15(3):354-360.
PMID: 37564218
PMC: 10411238.
DOI: 10.1055/s-0043-1761925.
Kerin E, Davey M, McLaughlin R, Sweeney K, Barry M, Malone C
Breast. 2022; 66:227-235.
PMID: 36335747
PMC: 9647009.
DOI: 10.1016/j.breast.2022.11.001.
Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
Cserni G, Francz M, Jaray B, Kalman E, Kovacs I, Krenacs T
Pathol Oncol Res. 2022; 28:1610373.
PMID: 35845921
PMC: 9284216.
DOI: 10.3389/pore.2022.1610373.
Advancement of prognostic models in breast cancer: a narrative review.
Min N, Wei Y, Zheng Y, Li X
Gland Surg. 2021; 10(9):2815-2831.
PMID: 34733730
PMC: 8514300.
DOI: 10.21037/gs-21-441.
Low-risk DCIS. What is it? Observe or excise?.
Pinder S, Thompson A, Wesserling J
Virchows Arch. 2021; 480(1):21-32.
PMID: 34448893
PMC: 8983540.
DOI: 10.1007/s00428-021-03173-8.
Preoperative Routine Laboratory Markers for Predicting Postoperative Recurrence and Death in Patients with Breast Cancer.
Yoo Y, Park S, Kim H, Jung H, Kim J, Kim M
J Clin Med. 2021; 10(12).
PMID: 34199276
PMC: 8231951.
DOI: 10.3390/jcm10122610.
Case Report: Dynamic Interdependencies Between Complementary and Alternative Medicine (CAM) Practice, Urinary Interleukin-6 Levels, and Fatigue in a Breast Cancer Survivor.
Singer M, Ott M, Bliem H, Hladschik-Kermer B, Ocana-Peinado F, Chamson E
Front Psychiatry. 2021; 12:592379.
PMID: 34149467
PMC: 8208488.
DOI: 10.3389/fpsyt.2021.592379.
Dynamic Effects of CAM Techniques on Inflammation and Emotional States: An Integrative Single-Case Study on a Breast Cancer Survivor.
Schubert C, Ott M, Hannemann J, Singer M, Bliem H, Fritzsche K
Integr Cancer Ther. 2021; 20:1534735420977697.
PMID: 33412954
PMC: 7797599.
DOI: 10.1177/1534735420977697.
One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.
Chocteau F, Mordelet V, Dagher E, Loussouarn D, Abadie J, Nguyen F
Vet Comp Oncol. 2020; 19(1):140-151.
PMID: 32954630
PMC: 7891631.
DOI: 10.1111/vco.12655.
Economic Evaluation of Population-Based Mutation Testing across Multiple Countries and Health Systems.
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, de Freitas Lopes A
Cancers (Basel). 2020; 12(7).
PMID: 32708835
PMC: 7409094.
DOI: 10.3390/cancers12071929.
Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.
Okuma H, Sudah M, Kettunen T, Niukkanen A, Sutela A, Masarwah A
PLoS One. 2020; 15(6):e0235278.
PMID: 32584887
PMC: 7316248.
DOI: 10.1371/journal.pone.0235278.
Comparison of Nottingham Prognostic Index, PREDICT and PrognosTILs in Triple Negative Breast Cancer -a Retrospective Cohort Study.
Sejben A, Nyari T, Zombori T, Cserni G
Pathol Oncol Res. 2020; 26(4):2443-2450.
PMID: 32564262
PMC: 7471141.
DOI: 10.1007/s12253-020-00846-8.
Radiological audit of interval breast cancers: Estimation of tumour growth rates.
MacInnes E, Duffy S, Simpson J, Wallis M, Turnbull A, Wilkinson L
Breast. 2020; 51:114-119.
PMID: 32298962
PMC: 7375675.
DOI: 10.1016/j.breast.2020.03.006.
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression.
Gagliano T, Shah K, Gargani S, Lao L, Alsaleem M, Chen J
J Clin Invest. 2020; 130(6):3188-3204.
PMID: 32125284
PMC: 7260014.
DOI: 10.1172/JCI128313.
Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer.
Dietzel M, Schulz-Wendtland R, Ellmann S, Zoubi R, Wenkel E, Hammon M
Sci Rep. 2020; 10(1):3664.
PMID: 32111898
PMC: 7048934.
DOI: 10.1038/s41598-020-60393-9.
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine.
Franco P, De Rose F, De Santis M, Pasinetti N, Lancellotta V, Meduri B
Clin Transl Radiat Oncol. 2020; 21:112-119.
PMID: 32090175
PMC: 7025960.
DOI: 10.1016/j.ctro.2020.02.003.
Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression.
Manning M, Jiang Y, Wang R, Liu L, Rode S, Bonahoom M
RNA Biol. 2020; 17(4):474-486.
PMID: 31957540
PMC: 7237164.
DOI: 10.1080/15476286.2019.1708549.
